Celcuity宣布发行4亿美元可转换票据

2026-06-03 19:41

Celcuity (NASDAQ: CELC) on Wednesday said that it plans to offer $400 million of convertible senior notes due 2032 in an underwritten public offering.
The clinical-stage biotechnology company said it expects to grant underwriters a 30-day option to purchase up to an additional $60 million of notes to cover over-allotments.
The unsecured senior notes will mature on August 1, 2032, unless earlier converted, redeemed, or repurchased.
The interest rate, conversion rate, offering price, and other terms will be determined at pricing.
Celcuity said it intends to use the net proceeds to repay all outstanding obligations under its loan agreement with Oxford Finance and use the remaining funds for working capital and general corporate purposes, including clinical trials, commercialization activities, research and development, capital expenditures, and business development.
The company said completion of the offering remains subject to market and other conditions, and there is no assurance regarding its timing, size, or final terms.
Source: Press Release

More on Celcuity